Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Reza Talaie

Vascular & Interventional Radiology Minneapolis, MN Medical Doctor

NPI 1487886271 CMS profile 2774267

701 Park Ave, Hennepin County Medical Center, Transitional Radiology, Minneapolis, MN 55415

Open in the dashboard

General payments

$63,585

163 records reported · program years 2019–2025

Research payments

$350

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$144,429 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Reza Talaie of Minneapolis, MN is reported in the CMS Open Payments database as having received $63,585 across 163 general payments and $350 in research payments paid to them. Separately, studies naming them as principal investigator received $144,429 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $37,400 55
2024 General $1,820 24
2023 General $2,672 20
2022 General $11,746 34
2022 Research $350 1
2021 General $9,399 23
2020 General $17 1
2019 General $532 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Reza Talaie
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Reza Talaie were reported at $37,400. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Reza Talaie Vascular & Interventional Radiology median Middle half National median
2019 $532 $422 $125–$1,555 $163
2020 $17 $200 $68–$652 $114
2021 $9,399 $280 $99–$866 $132
2022 $11,746 $433 $137–$1,497 $149
2023 $2,672 $506 $152–$2,019 $160
2024 $1,820 $556 $175–$1,930 $164
2025 $37,400 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $53,071 73 payments
  2. Boston Scientific Corporation $3,025 33 payments
  3. Bard Peripheral Vascular, Inc. $1,463 14 payments
  4. Siemens Medical Solutions USA, Inc. $1,200 1 payment
  5. Sirtex Medical Inc $1,115 6 payments
  6. SI-BONE, Inc. $1,017 3 payments
  7. Penumbra, Inc. $926 6 payments
  8. Abbott Laboratories $644 6 payments
  9. W. L. Gore & Associates, Inc. $422 5 payments
  10. Philips Electronics North America Corporation $189 2 payments
  11. Other $513 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $36,650 5 payments
  2. Consulting Fee $14,525 14 payments
  3. Food and Beverage $8,187 125 payments
  4. Travel and Lodging $4,100 18 payments
  5. Education $123 1 payment
Products named General payments · program years 2019–2025
  1. OSTEOCOOL RF ABLATION $7,747 10 payments
  2. CONCERTOTM $6,956 9 payments
  3. KYPHON EXPRESS II KYPHOPAK TRAY $2,080 7 payments
  4. OBSIDIO $1,453 3 payments
  5. SYMPLICITY G3 $1,435 11 payments
  6. OSTEOCOOL RF ABLATION SYSTEM $1,167 8 payments
  7. Concerto Versa $1,138 1 payment
  8. SIR-Spheres Microspheres $1,115 6 payments
  9. IN.PACT Admiral $1,091 7 payments
  10. INTELLIS ADAPTIVESTIM $1,076 3 payments
  11. Other $5,889 84 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $350 1 payment

Billing to Medicare

Part B · data year 2024 · 118 billing codes

Paid by Medicare

$40,400

Medicare's payments for the services billed

Medicare patients

188

Average age 67

Services billed

1,103

94 women, 94 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 53%
Diabetes 41%
Ischemic heart disease 41%
Depression 40%
Heart failure 38%
Arthritis 38%
Cancer 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

164 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record